Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| COSELA | trilaciclib | injection, powder, lyophilized, for solution, intravenous | 73462-101NDA |
Compare
Other companies listing trilaciclib
- Pharmacosmos A/S1 site · 10 NDC
Enquiry
Common questions
- Is G1 Therapeutics, Inc. FDA approved?
- G1 Therapeutics, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does G1 Therapeutics, Inc. make?
- 1 product is listed under G1 Therapeutics, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.